Omnicare (OCR) Reports In-Line Q2 EPS
Tweet
Share
E-mailGet Alerts OCR Hot Sheet
Price: $97.90 --0%
Financial Fact:
Settlement, litigation and other related charges: 57.7M
Today's EPS Names:
MSGM, SMID, VISL, More
Financial Fact:
Settlement, litigation and other related charges: 57.7M
Today's EPS Names:
MSGM, SMID, VISL, More
Join SI Premium – FREE
Omnicare (NYSE: OCR) reported Q2 EPS of $1.02, in-line with the analyst estimate of $1.02. Revenue for the quarter came in at $1.7 billion versus the consensus estimate of $1.68 billion.
For earnings history and earnings-related data on Omnicare (OCR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- L3Harris CEO steps down amid conduct review, shares drop
- INVO Fertility (IVF) Tops Q2 EPS by 105c
- Femasys Inc. (FEMY) Misses Q2 EPS by 20c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
